C2N Diagnostics receives $15M investment to advance its blood test for Alzheimer's disease
February 22, 2023 at 14:19 PM EST
The biotechnology startup plans to use its funding to develop a second version of its blood test that aims to help diagnose Alzheimer's disease.
